Wegovy out-of-pocket cost in 2026 spans an enormous range: as little as $25 a month with commercial insurance and the savings card, $199 a month cash through NovoCare Pharmacy for your first two fills, or the full $1,349 list price if none of the programmes fit you. Which number is yours comes down to what insurance you carry, not to finding a better coupon.
This page walks every legitimate 2026 payment path in order of cost, states the caps and expiry conditions each one carries, and shows what people do when none of them work. If you are paying cash and want the lowest number, compounded semaglutide through licensed telehealth undercuts every brand route, at the cost of being a different regulatory category.
🔑 Key Takeaways
- Your insurance decides the number, not your negotiating. Commercial plan that covers Wegovy gets you to $25. Everything else is a different ladder entirely.
- The savings card is capped at $100 a month. If your copay is $180, the card pays $100 and you pay the rest — the $25 headline assumes a copay the card can fully absorb.
- NovoCare self-pay is $199 for the first two fills only, then it rises to $349. Budget for the step-up rather than the introductory number.
- Medicare and Medicaid cannot use the savings card. Federal anti-kickback rules bar manufacturer copay assistance from government programmes.
- Patient assistance can reach $0 for people who are uninsured and meet Novo Nordisk’s income criteria, but it is an application, not a checkout discount.
What Wegovy actually costs out of pocket in 2026
Wegovy (semaglutide 2.4mg) is Novo Nordisk’s weight-management injection, dosed weekly and titrated over roughly sixteen weeks to a maintenance dose. Unlike some GLP-1s, the list price does not change with dose, so titration does not raise your cost.
The savings card, and the cap nobody quotes
With commercial insurance that covers Wegovy, the Novo Nordisk savings offer can bring you to as little as $25 a month. The condition people miss is the ceiling: the card contributes a maximum of $100 toward any single fill.
That means the $25 headline only holds if your plan’s copay is $125 or less. If your plan puts Wegovy on a specialty tier with a $250 copay, the card pays $100 and you pay $150 — a real saving, but six times the advertised price. Before assuming $25, look up your actual copay tier for semaglutide and subtract $100.
Check for a copay accumulator before you budget
Many commercial plans now run copay accumulator or maximiser programmes, under which the manufacturer’s contribution does not count toward your deductible or out-of-pocket maximum. You feel cheap through the spring and then discover in autumn that your deductible has barely moved. Ask your plan administrator directly whether copay assistance accrues to your deductible — the answer changes what a year of Wegovy really costs you.
Wegovy self-pay: the NovoCare route
If you have no coverage for Wegovy, Novo Nordisk sells it direct through NovoCare Pharmacy at a cash price well below retail. As of 2026 that is $199 a month for your first two fills, then $349 a month thereafter.
The introductory rate is the number that gets quoted in headlines; the $349 is the number you will actually live with. Over a year that is roughly $4,586 — substantially better than the $16,000 a list-price year would cost, and still a significant expense.
Wegovy prices outside the US
Wegovy is priced very differently by market, which is why “wegovy price in canada” and “wegovy price in mexico” are common searches. Both markets have historically listed the drug well below US retail.
Two cautions before you act on that. First, importing prescription medication into the United States for personal use sits in a legal grey area that the FDA does not formally sanction, whatever the practical enforcement picture. Second, cross-border supply chains for GLP-1s have been a recurring source of counterfeit pens; the FDA has issued warnings about falsified semaglutide entering circulation. If cost is the driver, the domestic cash and compounded routes below carry far less risk than sourcing abroad.
If you need a Wegovy prescription first
Wegovy is prescription-only. Getting one requires a clinician to confirm you meet the label criteria — broadly a BMI of 30 or more, or 27 or more alongside a weight-related condition such as hypertension, type 2 diabetes or sleep apnoea. Your own physician can prescribe it, and licensed telehealth services can as well, typically same-week. There is no legal route to Wegovy without a prescription, and sellers offering one are not supplying genuine Wegovy.
What people do when nothing fits
The most common outcome for cash payers is switching molecule rather than paying list. Compounded semaglutide — the same active ingredient, prepared by a compounding pharmacy rather than Novo Nordisk — is prescribed through licensed telehealth from roughly $69 a month. It is not an FDA-approved product and does not carry the brand’s trial evidence or manufacturing oversight, which is a genuine trade-off rather than a technicality. Our GLP-1 programme reviews compare the providers on price, process and what they actually dispense.
References
- Novo Nordisk. NovoCare savings and self-pay pricing. Savings card terms and NovoCare Pharmacy cash pricing. Accessed August 16, 2026.
- U.S. Food and Drug Administration. FDA communications on semaglutide supply and counterfeits.
- U.S. Food and Drug Administration. Drugs@FDA: Wegovy (semaglutide) labeling. Approved indication and BMI criteria.
